StemSight
Helsinki, FI · 1 known investors
StemSight develops stem cell-based therapies to restore sight, focusing on treatments for corneal conditions such as limbal stem cell deficiency using pluripotent stem cells. The company, spun out of the Skottman Lab's Eye Regeneration Group, targets patients with untreatable eye diseases in collaboration with cornea clinicians.
Founders & leadership
LK
Laura KoivusaloCEO
HS
Heli Skottman
Investors · 1
Funding
SEC filings, press & company announcements$2.3M disclosed across 1 round · 2025
- $2.3MraisedFeb 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does StemSight do?
- StemSight develops stem cell-based therapies to restore sight, focusing on treatments for corneal conditions such as limbal stem cell deficiency using pluripotent stem cells. The company, spun out of the Skottman Lab's Eye Regeneration Group, targets patients with untreatable eye diseases in collaboration with cornea clinicians.
- Who founded StemSight?
- StemSight was founded by Laura Koivusalo, Heli Skottman.
- Who are StemSight's investors?
- StemSight's investors include Voima Ventures.
- How much funding has StemSight raised?
- StemSight has disclosed $2.3M raised across 1 round.
- Where is StemSight headquartered?
- StemSight is headquartered in Helsinki, FI.